据欧盟食品安全局（EFSA）消息，2020年5月6日，欧盟食品安全局发布了关于噻苯唑（thiabendazole）农药风险评估的磋商结果。

 

　　应欧盟委员会要求，欧盟食品安全局就活性物质噻苯唑的风险评估方面提供了科学援助。本报告总结了报告成员国西班牙组织的磋商结果，并介绍了欧盟食品安全局对收到的个人意见的科学观点和结论。部分原文报道如下：

 

　　The European Food Safety Authority （EFSA） was asked by the European Commission to provide scientific assistance with respect to the risk assessment for an active substance in light of confirmatory data requested following approval in accordance with Article 6（1） of Directive 91/414/EEC and Article 6（f） of Regulation （EC）No 1107/2009. In this context EFSA's scientific views on the specific points raised during the commenting phase conducted with Member States, the applicant and EFSA on the confirmatory data and their use in the risk assessment for thiabendazole are presented. The current report summarises the outcome of the consultation process organised by the rapporteur Member State,Spain, and presents EFSA's scientific viewsand conclusions on the individual comments received.